BAX - Baxter International Inc.
85.03 0.00 (0.00%)
After hours: 4:15PM EDT
| Previous Close | 87.21 |
| Open | 87.25 |
| Bid | 85.06 x 800 |
| Ask | 85.09 x 800 |
| Day's Range | 84.62 - 87.34 |
| 52 Week Range | 61.05 - 88.48 |
| Volume | 1,736,870 |
| Avg. Volume | 2,234,025 |
| Market Cap | 43.413B |
| Beta (3Y Monthly) | 1.09 |
| PE Ratio (TTM) | 28.46 |
| EPS (TTM) | 2.99 |
| Earnings Date | Oct 24, 2019 |
| Forward Dividend & Yield | 0.88 (1.01%) |
| Ex-Dividend Date | 2019-08-29 |
| 1y Target Est | 92.60 |
- Zacks
National Vision's Store Launches on Track Despite Cost Woes
National Vision (EYE) adopts a formula-based approach to open around 75 stores in 2019.
- Zacks
Veeva (VEEV) Introduces MuleSoft Connector for Vault Platform
Veeva's (VEEV) Vault platform sees a slew of developments in recent times.
- Zacks
Edwards Lifesciences Sapien 3 System Recall Classified Class I
Edwards Lifesciences (EW) initiated the Field Corrective Action after receiving reports of 17 injuries and a death from the use of the Sapien 3 Ultra delivery system.
- Zacks
Here's Why You Should Retain Bio-Rad (BIO) Stock for Now
Investors' confidence continues to be high on solid prospects of Bio-Rad (BIO).
- Zacks
Abbott's Libre Adoption a Positive, Rhythm Management a Woe
Abbott (ABT) is steadily riding high on a healthy growth track within its Diabetes Care business.
- Zacks
Zimmer Biomet Wins Nod for Spinal Teather to Treat Scoliosis
Zimmer Biomet's (ZBH) AVBT solution, The Tether, uses a solid, flexible cord in place of traditional metal rods to pull on the outside of a scoliosis curve.
- Zacks
Allscripts' (MDRX) Veradigm Collaborates With Komodo Health
Allscripts (MDRX) expects its Veradigm business to drive bookings in 2019.
- Zacks
Genomic Health Test to Guide Chemo Per New Breast Cancer Rule
This is a major development in Genomic Health's (GHDX) endeavor to strengthen its breast cancer treatment portfolio.
- Zacks
Tandem Diabetes Rides on t:slim X2 Uptake, Product Pipeline
Robust domestic sales along with a strong unveiling of the t:slim X2 Insulin Pump in the international markets augur well for Tandem Diabetes (TNDM).
- Zacks
FDA OKs Medtronic's Evolut TAVR New Indication for Low Risk
With the FDA's expanded indication nod, Medtronic's (MDT) Evolut TAVR platform now comes in handy for treating symptomatic severe aortic stenosis patients across all risk categories.
- Zacks
Here's Why You Should Hold on to McKesson (MCK) Stock Now
McKesson (MCK) is gaining from strong segmental performance and solid prospects in the pharmaceutical and medical supplies distribution market.
- Zacks
Here's Why You Should Add Stryker (SYK) to Your Portfolio
Stryker (SYK) gains from core segments in the second quarter of 2019.
- Zacks
Restoration Robotics (HAIR) Wins CE Mark for ARTAS iX System
This regulatory approval is expected to strengthen Restoration Robotics' (HAIR) hair restoration business and expand its presence globally.
- Business Wire
The Baxter International Foundation and Direct Relief Launch Program to Improve Diabetes Care in Underserved Communities
The Baxter International Foundation, the philanthropic arm of Baxter International Inc. (BAX), and the global humanitarian organization Direct Relief announced today the launch of the Transformative Innovation Awards for Community Health: Incorporating Nutrition to Improve Diabetes Health Outcomes. The three-year program will award $750,000 in funding to health centers and free and charitable clinics that are working to improve diabetes health outcomes for patients, focusing on the Greater Chicago area in the first year. “Ensuring that individuals from all communities and neighborhoods have access to needed health resources is one of the reasons that we partner with companies like Baxter,” said Thomas Tighe, president and CEO, Direct Relief.
- Zacks
Medtronic (MDT) Beats on Q1 Earnings, Ups FY20 EPS Guidance
Medtronic (MDT) displays improved performances at CER, banking on growth across all major segmental businesses as well as geographies.
- Zacks
BAX vs. BSX: Which Stock Is the Better Value Option?
BAX vs. BSX: Which Stock Is the Better Value Option?
- Zacks
Here's Why You Should Hold Varian Medical (VAR) Stock Now
Varian (VAR) raises the revenue guidance for fiscal 2019.
- Zacks
Walgreens (WBA) Expands Partnership With Retail Giant Kroger
The extended partnership deal with Kroger will help Walgreens (WBA) strengthen its market presence.
- Zacks
Here's Why You Should Hold Onto IDEXX (IDXX) Stock for Now
Investor confidence continues to be high on IDEXX Laboratories' (IDXX) prospects.
- Zacks
Here's Why You Should Invest in DaVita (DVA) Stock For Now
DaVita (DVA) continues to benefit from international expansion, strategic buyouts and strong demand of dialysis services.
- Zacks
Here's Why You Should Retain Nevro (NVRO) in Your Portfolio
Nevro (NVRO) is gaining traction from a fortified international footprint and solid prospects in the SCS market. However, stiff competition remains a woe.
- Zacks
Here's Why You Should Retain Wright Medical Stock For Now
Wright Medical (WMGI) continues to benefit from strong international sales, new product launches and solid prospects in the global Orthopedic space. However, forex remains a woe.
- Zacks
Edwards Lifesciences' (EW) SAPIEN 3 TAVR Receives FDA Nod
Edwards Lifesciences (EW) plans a commercial introduction of SAPIEN 3 Ultra in Europe.
- Zacks
Here's Why You Should Hold Onto Omnicell (OMCL) Stock for Now
Investor confidence continues to be high on Omnicell's (OMCL) prospects.
- Zacks
QIAGEN Posts QIAstat-Dx Gastrointestinal Panel Study Results
The study outcome has been a major step for QIAGEN (QGEN) toward offering accurate diagnosis and treatment of gastroenteritis.
